CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education (CE) for retail, health-system, managed care, oncology and specialty pharmacists, in partnership with the National Association of Specialty Pharmacy (NASP), have released a five-part, educational, on-demand CE webinar curriculum, “Multifaceted Management of Cystic Fibrosis: Optimizing the Knowledge and Ability of Pharmacists.”
The curriculum features five modules, each with a different expert faculty presenter:
- Module 1—Pediatric Patients With Cystic Fibrosis: Rebecca Pettit, Pharm.D., MBA, BCPS, BCPPS, pediatric pulmonary clinical specialist, Riley Hospital for Children, Indiana University Health.
- Module 2—Managing Acute Pulmonary Exacerbations: Paul Beringer, Pharm.D., professor and chair, Titus Family Department of Clinical Pharmacy, University of Southern California.
- Module 3—Chronic Medications in Cystic Fibrosis: Lisa Lubsch, Pharm.D., BCPPS, AE-C, FPPAG, clinical professor, department of pharmacy practice, Southern Illinois University Edwardsville School of Pharmacy, and pediatric clinical pharmacy specialist, Cardinal Glennon Children’s Hospital.
- Module 4—Managing Cystic Fibrosis-Related Complications: Claire Elson, Pharm.D., BCPPS, clinical pharmacy specialist, cystic fibrosis/pulmonology, department of pharmacy, Children’s Mercy Kansas City.
- Module 5—Cystic Fibrosis Communication and Counseling Tips: Cameron J. McKinzie, Pharm.D., BCPPS, BCPS, CPP, residency program director - PGY2 pediatrics, and clinical pharmacist practitioner, outpatient pediatric pulmonary, University of North Carolina Children’s Hospital.
“Study results show that approximately 70,000 individuals are living with cystic fibrosis (CF) globally,” said Jim Palatine, RPh, MBA, president of PTCE. “In this five-module, on-demand webinar curriculum, we look forward to educating the pharmacy community on how to manage this disease and improve the quality of life for patients living with CF. Participants can also receive a certificate of completion when they complete the full cubiculum.”
This educational curriculum is designed to cover unique considerations in the management of CF. Completing these CE modules will keep pharmacists abreast of specialized information about the management of pediatric patients, pulmonary exacerbations, chronic medications and adherence, complications and key counseling points as well as a look ahead to upcoming treatments. Participants who complete all five activities in this series will receive a certificate that demonstrates the pharmacist’s dedication to improving their knowledge of CF treatment and management. Accredited by the Accreditation Council for Pharmacy Education, each CE module can be completed as individual activities or the full curriculum for a total of 5.5 CE credits.
The activity is supported by educational grants from Vertex Pharmaceuticals Incorporated and Rare Disease Report®. PTCE acknowledges the National Association of Specialty Pharmacy for its contributions to the development of this activity.
To learn more and to participate, click here.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to improve the knowledge, competence and skills of pharmacists to better prepare them to provide the highest quality of pharmacy care to the patients they serve and the physicians they assist as part of a multidisciplinary treatment and management team. PTCE is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.
About the National Association of Specialty Pharmacy (NASP)
The National Association of Specialty Pharmacy (NASP) is a 501(c)(6) nonprofit trade organization and the only national association representing all stakeholders in the specialty pharmacy industry, including the nation’s leading specialty pharmacies, pharmaceutical and biotechnology manufacturers, health plans and integrated delivery systems, wholesalers, group purchasing organizations, and pharmacy benefit managers. The mission of NASP is to elevate the practice of specialty pharmacy by developing and promoting continuing professional education and certification of specialty pharmacists, as well as advocating for public policies that ensure patients have appropriate access to specialty medications in tandem with critical services. The association provides an online education center offering accredited continuing pharmacy education programs, hosts an annual meeting that offers education sessions and continuing education credits and is the only organization that offers a certification program for specialty pharmacists. NASP members include the nation’s leading independent specialty pharmacies, pharmaceutical and biotechnology manufacturers, group purchasing organizations, patient advocacy groups, integrated delivery systems and health plans, technology and data management vendors, wholesalers/distributors and practicing pharmacists. With over 100 corporate members and 1,500 individual members, NASP is the unified voice of specialty pharmacy in the United States.
